Favorable demographics with a dynamic, young and skilled talent pool supporting the industry
Heavy investments in healthcare infrastructure and services
Increasing life expectancy and spending in healthcare
Export opportunities due to Turkey’s proximity to regional markets
Ideal location for clinical trials and a favorable regulatory environment aligned with international standards
Global biotechnologies companies have been present in Turkey with significant manufacturing activities, using Turkey as a hub to access regional markets
İBG – İzmir Biomedicine and Genome Center’s mission is to develop innovative technologies and products for the prevention, diagnosis and treatment of diseases using basic research in life sciences as a driving force. IBG houses basic and translational research programs, technological research programs, industrial R&D programs working on biomedicine and genome sciences.
IBG has an enclosed space of approximately 22,250 m2, which includes the research laboratories, cell culture laboratories, equipped rooms for common use.